GENEVA, May 3 -- NANJING REJU THERAPEUTICS CO., LTD. (109-29, Building 6, Zhilan Road 18, Jiangning (Jiangning High-tech Park)Nanjing, Jiangsu 210000), 南京瑞初医药有限公司 (中国江苏省南京市江宁区芝兰路18号6栋109-29（江宁高新园）) filed a patent application (PCT/CN2025/090159) for "NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE AGONIST AND USE THEREOF" on Apr 21, 2025. With publication no. WO/2026/086133, the details related to the patent application was published on Apr 30, 2026.
Notably, the patent application was submitted under the International Pat...